President Trump tells reporters he knows nothing about reports suggesting FDA commissioner Marty Makary will be asked to resign soon.
FDA seeks public input on ways to expand drug repurposing efforts, aiming to accelerate treatment options for patients with unmet medical needs by identifying new uses for already approved medicines.
President Trump tells reporters he knows nothing about reports suggesting FDA commissioner Marty Makary will be asked to resign soon.
FDA seeks public input on ways to expand drug repurposing efforts, aiming to accelerate treatment options for patients with unmet medical needs by identifying new uses for already approved medicines.
FDA delays by three months its decision on Eisai and Biogen's subcutaneous starting-dose formulation of Alzheimer’s drug Leqembi (lecanemab) after the agency requested additional information during its review.
An FDA inspection cites multiple quality control and aseptic processing concerns at Staska Pharmaceuticals.
